Kellie Meyer
Kellie Meyer, PharmD, MPH, is a Director within the Global Outcomes Solutions team. Dr. Meyer’s primary responsibilities include the marketing, development, and implementation of strategies and services that measure and communicate the value of pharmaceuticals and other healthcare technologies. More specifically, she supports client projects related to market research, database analyses, economic modeling, outcomes analyzers, strategy engagements, disease and/or drug resource utilization evaluations, outcomes research education/training programs, dossier and formulary kit development, and REMS-related strategic consulting.
Dr. Meyer has been responsible for design, management, and content development of clinical and disease intervention programs that are consistent with the National Committee for Quality Assurance (NCQA)’s accreditation standards. She has authored several scientific publications, including works published in Current Medical Research & Opinion. Kellie has presented at numerous healthcare meetings and is a member of the Academy of Managed Care Pharmacy and the International Society for Pharmacoeconomics and Outcomes Research.
Dr. Meyer’s therapeutic experience includes multiple sclerosis, hereditary angioedema, schizophrenia, psoriasis, depression, acne, diabetes, irritable bowel syndrome, hematopoietic stem cell transplantation due to non-Hodgkin’s lymphoma and multiple myeloma, pain management, insomnia, and allergic rhinitis.
Dr. Meyer received her Doctor of Pharmacy degree from the Northeastern University Bouve` College of Health Sciences School of Pharmacy in 2001. Her post-doctoral training includes a pharmacy practice residency at The Johns Hopkins Hospital and an outcomes research fellowship at Xcenda. Dr. Meyer also received a Master of Public Health in Epidemiology from the University of South Florida College of Public Health.
